Annual Review of Biomedical Engineering, published by Annual Reviews, stands as a leading academic journal dedicated to the rapidly evolving field of biomedical engineering. With an impressive impact factor that reflects its high citation rates and rigorous peer-review process, this journal offers critical insights by synthesizing cutting-edge advancements and applications in both biomedical engineering and miscellaneous medicine. The journal, which is available in both print (ISSN: 1523-9829) and electronic formats (E-ISSN: 1545-4274), serves as an essential resource for researchers, professionals, and students aiming to stay abreast of significant developments and emerging trends. As of 2023, it is recognized in the top tier (Q1) for both Biomedical Engineering and Medicine, showcasing its esteemed position within the academic community, reflected in its high Scopus rankings. Spanning from 1999 to 2024, the Annual Review of Biomedical Engineering continues to catalyze interdisciplinary collaboration and innovation at the intersection of engineering and healthcare.

BioChip Journal, published by the Korean Biochip Society (KBCS), is a renowned academic platform dedicated to advancing the fields of bioengineering, biomedical engineering, biotechnology, and electrical and electronic engineering. With its ISSN 1976-0280 and E-ISSN 2092-7843, this esteemed journal has established itself as a valuable resource for researchers, professionals, and students alike, providing them with cutting-edge research and insights since its inception in 2008. The journal has earned a commendable standing in the academic community, achieving Q2 ranking across key categories, thereby placing it amongst the top-tier publications. With its impressive Scopus rankings, including a top 10% position in Electrical and Electronic Engineering and a strong showing in both Biomedical Engineering and Biotechnology, BioChip Journal plays a vital role in disseminating innovative biochip technologies and applications. The journal continues to invite groundbreaking studies and reviews that promote the interdisciplinary collaboration essential for the future of biochip research, ultimately contributing to advancements in healthcare, diagnostics, and therapeutics.

SENSORS is a leading peer-reviewed open-access journal published by MDPI, dedicated to the field of sensor technology and its applications. Established in 2001 and located in Basel, Switzerland, this journal plays a pivotal role in disseminating groundbreaking research encompassing various disciplines, including Analytical Chemistry, Physics, Engineering, and Biochemistry. With a distinguished 2023 Scopus ranking that places it in Q1 across multiple categories and a commendable impact factor reflective of its high-quality contributions, SENSORS has cemented its status as an essential resource for researchers and professionals alike. The journal is committed to facilitating knowledge exchange in cutting-edge sensor technologies, fostering advancement in areas such as instrumentation, medical applications, and electronic engineering. The convenient open-access model ensures that research findings are readily accessible to a global audience, promoting collaboration and innovation within the scientific community. For all those interested in probing the depths of this dynamic field, SENSORS provides a rich repository of research that not only informs but inspires future explorations.

Biomedical Engineering Online, published by BMC, is an esteemed open-access journal in the United Kingdom that has been advancing the field of biomedical engineering since its inception in 2002. With a commitment to disseminating high-quality research, the journal encompasses a broad scope, including innovative studies in biomaterials, imaging technologies, and medical applications. Recognized within the Q2 quartile for various categories such as Biomaterials and Biomedical Engineering, it ranks favorably among its peers: Rank #58 out of 333 in Radiology, and Rank #15 out of 63 in Radiological and Ultrasound Technology in the Scopus database. These rankings, coupled with an open-access model, ensure that critical advancements in medical technology are accessible to researchers, health professionals, and students globally. As it continues through its converged years from 2002 to 2024, Biomedical Engineering Online remains an invaluable resource for anyone involved in the cutting-edge intersection of engineering and medicine.

Biomedical Engineering Letters, published by SpringerNature, is a prominent journal in the field of Biomedical Engineering. With a robust ISSN of 2093-9868 and E-ISSN of 2093-985X, this esteemed journal has established itself as a vital resource for researchers and professionals seeking to advance their knowledge and share groundbreaking findings. Recognized for its quality, Biomedical Engineering Letters holds a distinguished ranking in Scopus, positioned at #94/303 (69th percentile) in the Biomedical Engineering category. The journal covers a diverse scope within biomedical engineering, providing an important platform for innovative research from 2011 to 2024 and facilitating the exchange of ideas among scholars. Although it operates under a subscription model, the journal's commitment to enhancing the field makes it an indispensable reference for those engaged in cutting-edge biomedical research in Germany and globally.

Advanced NanoBiomed Research is a pioneering open-access journal committed to advancing the interdisciplinary field of nanobiotechnology, published by WILEY-V C H VERLAG GMBH. Since its inception in 2021, this journal has provided a platform for innovative research that bridges the gap between engineering, medicine, and materials science. With impressive rankings in Scopus, positioning it within the top quartiles of various categories, Advanced NanoBiomed Research aims to disseminate high-quality research that contributes to the understanding and application of nanomaterials in biomedical contexts. As it encompasses a wide scope—from applied microbiology to biomaterials—it serves as an essential resource for researchers, professionals, and students eager to explore the cutting-edge developments in the field. The journal promotes a collaborative environment where emerging ideas can flourish, ensuring that vital advancements in nanobiomedicine can be shared and built upon within the scientific community.

VIEW is a prestigious journal published by WILEY that focuses on the rapidly evolving fields of Biomaterials and Biomedical Engineering. Since its inception in 2020, VIEW has established itself as an open-access platform dedicated to disseminating high-quality research and innovation within these disciplines. With an impressive impact factor that places it in the Q1 category of both Biomaterials and Biomedical Engineering, VIEW ranks among the top journals in its field, boasting a 91st percentile ranking in Biomedical Engineering and an 85th percentile ranking in Materials Science. Researchers, professionals, and students are encouraged to utilize this invaluable resource, as it provides a comprehensive view of current advancements and future trends in biomaterial science and engineering. Positioned in the United Kingdom, VIEW operates as a vital scholarly communication link, fostering collaboration and knowledge sharing within an ever-growing global community.

Nanotechnology Science and Applications, published by DOVE MEDICAL PRESS LTD, is a premier open-access journal dedicated to advancing knowledge in the fields of nanoscience and nanotechnology, particularly focusing on their applications in bioengineering, biomedical engineering, and pharmaceutical sciences. Since its inception in 2008, this journal has provided a platform for the dissemination of high-quality research that is rigorously peer-reviewed, ensuring that only the most impactful findings reach a global audience. With an impressive impact factor reflected in its recent categorization in the Q1 tier for Pharmaceutical Science and Q2 for Bioengineering and Nanoscience, it stands as a critical resource for researchers, practitioners, and students eager to explore the cutting-edge innovations within these rapidly evolving disciplines. The journal's commitment to accessibility and its robust indexing in Scopus—ranked highly in its respective categories—reinforces its importance as a leading forum for the exchange of scientific knowledge and the fostering of collaborative research in nanotechnology applications.

ANNALS OF BIOMEDICAL ENGINEERING is a premier journal in the field of biomedical engineering, published by Springer. Established in 1972, this journal has become a vital resource for researchers, professionals, and students engaged in the rapidly evolving domain of biomedical technology. With a commendable impact factor and ranked in the 76th percentile among its peers as per Scopus, it exemplifies excellence in disseminating critical research findings. The journal covers a broad scope of topics related to the integration of engineering principles with medical and biological sciences, facilitating innovations that enhance healthcare outcomes. Although open access is not offered in this journal, it remains an essential platform for scholarly communication, contributing to the continuous advancement of knowledge in biomedical engineering. ANNALS OF BIOMEDICAL ENGINEERING is not only a bridge for academics to share groundbreaking research but also an influential guide for practical applications in medicine and health technologies, making it a fundamental publication for its readership.

Bioengineering & Translational Medicine, published by WILEY, positions itself at the forefront of innovation in the fields of biomedical engineering, biotechnology, and pharmaceutical science. With an impressive impact factor reflected through its top-tier Q1 rankings in multiple categories, the journal serves as a critical platform for disseminating cutting-edge research and stimulating discourse among professionals and scholars since its establishment as an open-access journal in 2016. Key to its mission is facilitating the translation of bioengineering research into tangible medical applications, thereby enhancing healthcare outcomes. With its comprehensive scope, it attracts a diverse readership, including researchers, industry leaders, and students eager to engage with the latest developments in translational medicine. The journal operates under robust access options, ensuring that research is freely available for maximum reach and impact, fostering collaboration and innovation across disciplines worldwide.